Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
NCT ID: NCT04300257
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2019-10-19
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
National Swiss Sarcoma Cohort Study
NCT02775799
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
NCT00826579
Liquid Biopsy in Mature B-cell Tumors
NCT03280394
The ONCOCAMP Study
NCT06270602
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The outcome variables include patient characteristics, tumor types and characteristics, histology, management and treatment strategies as well as recurrence rate and overall survival.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female and male subjects of all ages
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Sarcoma Network
UNKNOWN
Kantonsspital Winterthur KSW
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Fuchs, Prof
Role: PRINCIPAL_INVESTIGATOR
SwissSarcomaNetwork
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland
SwissSarcomaNetwork
Winterthur, Canton of Zurich, Switzerland
Ente Ospedaliero Cantonale
Bellinzona, Canton Ticino, Switzerland
Kantonsspital Graubünden
Chur, Kanton Graubünden, Switzerland
Luzerner Kantonsspital
Lucerne, , Switzerland
Pathologie Institut Enge
Zurich, , Switzerland
Klinik Hirslanden
Zurich, , Switzerland
Stadtspital Zürich Triemli
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stefan Breitenstein, Prof. Dr. med.
Role: primary
Silke Gillessen Sommer, Prof. Dr. med.
Role: primary
Christian Michelitsch, Dr. med.
Role: primary
Gabriela Studer, Prof. Dr. med.
Role: primary
Beata Bode, Prof. Dr. med.
Role: primary
Annelies Schnider, Dr. med.
Role: backup
Markus Weber, Prof. Dr. med. Dr. h.c.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Delgado Bolton R, Donati DM, Douis H, Haas R, Hogendoorn P, Kozhaeva O, Lavender V, Lovey J, Negrouk A, Pereira P, Roca P, de Lempdes GR, Saarto T, van Berck B, Vassal G, Wartenberg M, Yared W, Costa A, Naredi P. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review. Crit Rev Oncol Hematol. 2017 Feb;110:94-105. doi: 10.1016/j.critrevonc.2016.12.002. Epub 2016 Dec 8.
Abarca T, Gao Y, Monga V, Tanas MR, Milhem MM, Miller BJ. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol. 2018 Jun;117(7):1479-1486. doi: 10.1002/jso.25052. Epub 2018 Apr 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-01107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.